SCHEMBL7671933

SCHEMBL7671933

CC(C)(C)OC(=O)CNS(=O)(=O)c1cccc(C(=O)Oc2ccc(C(=N)N)cc2)c1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F2 P00734 19/20 0.56
TMPRSS6 Q8IU80 12/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7665205 0.89 F2 (0.58) F2TMPRSS6
SCHEMBL7669520 0.89 F2 (0.58) F2TMPRSS6
SCHEMBL7674656 0.86 F2 (0.53) F2TMPRSS6
SCHEMBL7667753 0.82 F2 (0.52) F2TMPRSS6
SCHEMBL7673733 0.80 MAPT (0.49) F2TMPRSS6
SCHEMBL7676248 0.79 F2 (0.57) F2TMPRSS6
SCHEMBL7690859 0.79 MEP1B (0.62) F2TMPRSS6
SCHEMBL7675632 0.78 SMN1; SMN2 (0.51) F2TMPRSS6
Acetic Acid SCHEMBL7667840 0.77 TMPRSS6 (0.55) F2TMPRSS6
Acetic Acid SCHEMBL7663094 0.77 TMPRSS6 (0.55) F2TMPRSS6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed